Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128851) titled 'Real World Study of Cofrogliptin' on July 27.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Third Affiliated Hospital of Sun Yat-sen University
Condition:
T2DM
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-08-01
Target Sample Size: Cofrogliptin treatment group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=322878
Published by HT Digital Content Services with permission from Health Daily Digest....